Email Us Here

Lumos Pharma Receives Wellcome Trust Award for Advancing Potential Treatment of Creatine Transporter Deficiency (CTD)

Lumos Pharma, Inc. (Austin, Texas) announced today that it has received an award of up to $5.5 million from the Translation Fund of the Wellcome Trust.